Screener
Pacira BioSciences, Inc. PCRX Income Tax
Income Tax at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The source filing: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028871
| Line item | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Other, net | (135) | 4,401 |
| Total other (expense) income, net | (1,904) | 6,716 |
| Income before income taxes | 4,998 | 8,706 |
| Income tax expense | (2,082) | (3,894) |
| Net income | $2,916 | $4,812 |
| Net income per common share: | ||
| Basic and diluted net income per common share | $0.07 | $0.10 |
| Weighted average common shares outstanding: |
Item 1. FINANCIAL STATEMENTS (Unaudited)
FAQ
- What is Pacira BioSciences, Inc.'s income tax?
- Pacira BioSciences, Inc. (PCRX) reported income tax of $2.08M in Q1 2026.
- How has Pacira BioSciences, Inc.'s income tax changed year-over-year?
- Pacira BioSciences, Inc.'s income tax decreased by 46.5% year-over-year, from $3.89M to $2.08M.
- What is the long-term trend for Pacira BioSciences, Inc.'s income tax?
- Over 3 years (2021 to 2024), Pacira BioSciences, Inc.'s income tax has grown at a 33.0% compound annual growth rate (CAGR), from $15.49M to $36.45M.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.
Ask your AI about Pacira BioSciences, Inc.'s income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude